Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Silexion Therapeutics Ltd. | StockGist | StockGist

Companies
SLXNW
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings SLXNWSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Silexion Therapeutics Ltd.

Filed May 13, 2025

Accepted May 12, 2025, 8:00 PM ET

CIK 0002022416

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

4.00%

Shares Owned

4

Reporting Person

Silexion Therapeutics Corp

Person Type

HC

Amendment History

9 filings

SCHEDULE 13G
Original
Sep 18, 20250000929638-25-003514
SCHEDULE 13G/A
Amendment 1
May 12, 20250001649553-25-000095
SCHEDULE 13G/A
Amendment 2
May 12, 20250001649553-25-000095
SCHEDULE 13G/A
Amendment 3
Viewing
May 13, 20250000769993-25-000290
SCHEDULE 13G/A
Amendment 4
Viewing
May 13, 20250000769993-25-000290
SCHEDULE 13G/A
Amendment 5
Nov 14, 20250000929638-25-004297
SCHEDULE 13G/A
Amendment 6
Nov 14, 20250000929638-25-004297
SCHEDULE 13G/A
Amendment 7
Feb 13, 20260001213900-26-016532
SCHEDULE 13G/A
Amendment 8
Latest
Feb 13, 20260001213900-26-016532

Key Facts

% of Class

4.00%

Shares Owned

4

Recent Filings

Silexion Therapeutics Ltd.1 weeks ago

Silexion Therapeutics Ltd.1 weeks ago

Silexion Therapeutics Ltd.1 months ago

Silexion Therapeutics Ltd.2 months ago

Silexion Therapeutics Ltd.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice